Evaluating the acute toxicity and hepatoprotective effect of PROTECFUL hard capsule on paracetamol-induced acute hepatitis in mice
Nội dung chính của bài viết
Tóm tắt
Drug-induced liver injury is characterized by liver damage due to pharmaceutical compounds, resulting in a wide range of liver disorders, from asymptomatic elevations in liver enzymes to full liver failure. It is a leading cause of acute liver failure in many countries. This study investigated the acute toxicity and evaluated hepatoprotective effects on paracetamol-induced acute hepatitis of PROTECFUL hard capsules in Swiss mice. The acute toxicity was assessed through oral administration, and a fifty percent lethal dose was determined using the Litchfield-Wilcoxon method. In the paracetamol-induced acute hepatitis model, mice were orally administered distilled water, silymarin at 140 mg/kg per day, or PROTECFUL hard capsules at 345.6 and 1036.8 mg/kg/day. All indexes, including biochemical indicators (AST, ALT), liver malondialdehyde, glutathione concentration, and microscopic liver images, were evaluated. Regarding acute toxicity, our findings showed that the maximum tolerated dose was 35.4 times higher than the expected human dose without symptoms of acute toxicity. PROTECFUL-treated groups at both doses tended to decrease liver weight and lower liver enzyme activity compared to the model group. The histopathological examination of the liver in the PROTECFUL-treated groups tended to reduce liver degeneration and inflammatory cell infiltration. In summary, these findings suggest that PROTECFUL shows no acute toxicity and tends to have a hepatoprotective effect against paracetamol-induced liver injury.
Chi tiết bài viết
Từ khóa
PROTECFUL, hepatoprotective, acute toxicity, paracetamol-induced acute hepatitis, Swiss mice
Tài liệu tham khảo
2. David S, Hamilton JP. Drug-induced Liver Injury. Gastroenterology and Hepatology Review. 2010;6:73.
3. Kumachev A, Wu PE. Drug-induced liver injury. Canadian Medical Association Journal. 2021;193(9):E310.
4. Vargas-Mendoza N, Madrigal-Santillán E, Morales-González Á, et al. Hepatoprotective effect of silymarin. World Journal of Hepatology. 2014;6(3):144-149.
5. Salem MB, Affes H, Ksouda K, et al. Pharmacological Studies of Artichoke Leaf Extract and Their Health Benefits. Plant Foods for Human Nutrition. 2015;70(4):441-453.
6. Corbin KD, Zeisel SH. Choline metabolism provides novel insights into nonalcoholic fatty liver disease and its progression. Current Opinion in Gastroenterology. 2012;28(2):159-165.
7. Butterworth RF. L-Ornithine L-Aspartate for the treatment of sarcopenia in chronic liver disease: The taming of a vicious cycle. Canadian Journal of Gastroenterology and Hepatology. 2019;2019:8182195.
8. Saadati S, Sadeghi A, Mansour A, et al. Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial. BMC Gastroenterol. 2019;19(1):133.
9. Pacific WHORO for the W. Research guidelines for evaluating the safety and efficacy of herbal medicines. 2024.
10. Nhung Bui Thi Quynh. Evaluation on the protection effect of the vismisco in the liver damage induced by paracetamol in mice experiment. Gut. 2024;68(Suppl):A1-A166.
11. Altamirano J, Miquel R, Katoonizadeh A, et al. A histologic scoring system for prognosis of patients with alcoholic hepatitis. Gastroenterology. 2014;146(5):1231-1239.
12. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry. 1979;95(2):351-358.
13. Rahman I, Kode A, Biswas SK. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nature Protocols. 2006;1(6):3159-3165.
14. Li M, Wang Y, Lv TT, et al. Mapping the incidence of drug-induced liver injury: A systematic review and meta-analysis. Journal of Digestive Diseases. 2023;24(5):332-339.
15. Coelho AM, Queiroz IF, Lima WG, et al. Temporal analysis of paracetamol-induced hepatotoxicity. Drug and Chemical Toxicology. 2023;46(3):472-481.
16. Bao Y, Wang P, Shao X, et al. Acetaminophen-Induced Liver Injury Alters Expression and Activities of Cytochrome P450 Enzymes in an Age-Dependent Manner in Mouse Liver. Drug Metabolism and Disposition. 2020;48(5):326-336.
17. Günfer Turguta,Yaşar Enlib, Bünyamin Kaptanoğlu, et al. Changes in the levels of MDA and GSH in mice serum, liver and spleen after aluminum administration. Eastern Journal of Medicine. 2006;11:7-12.